Bio-Rad Labs (BIO) Tops Q2 EPS by 37c
Tweet
Share
E-mail
Get Alerts BIO Hot Sheet
Price: $296.11 --0%
Revenue Growth %: -4.3%
Financial Fact:
Income from operations: 22.53M
Today's EPS Names:
CCEL, MHGU, PLG, More
Revenue Growth %: -4.3%
Financial Fact:
Income from operations: 22.53M
Today's EPS Names:
CCEL, MHGU, PLG, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q2 EPS of $1.64, $0.37 better than the analyst estimate of $1.27. Revenue for the quarter came in at $575.9 million versus the consensus estimate of $548.43 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Truist upgrades Biogen to Buy on Alzheimer's, pipeline optimism ahead of key data
- Mach Natural Resources (MNR) PT Lowered to $20 at Stephens
- Delta Air Lines (DAL) Tops Q2 EPS by 3c, Beats on Revenue; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
